To survey the pattern of CD33 splice variant expression in human AML, we took advantage of whole transcriptome RNA sequencing (RNAseq) data from 61 pre-treatment bone marrow and 7 peripheral blood specimens collected from pediatric patients with newly diagnosed AML. This evidence concerns the gene CD33 and acute myeloid leukemia.